Eftersom lansoprazol hurtigt inaktiveres af mavesyre, administreres det peroralt som enterogranulat for at opnå systemisk absorption.
As lansoprazole is rapidly inactivated by gastric acid, it is administered orally in enteric-coated form(s) for systemic absorption.